Почетна › Склеродерма › Њујорк
Kliničke studije za Склеродерма u državi Њујорк
10 studija za Склеродерма traži učesnike na lokacijama u državi Њујорк.
Gradovi u državi Њујорк
Zvanični tekst studije (na engleskom)
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- NYU Langone Hospital - Long Island, Mineola
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- и још 1
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT03816345A Study of AZD0120 in Autoimmune Diseases
- Research Site, New York
- Research Site, New York
Тражи се учесникФаза 1/2
Узраст од 18 до 75 · Оба пола · Ажурирано 10. 11. 2026. · NCT07295847A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Icahn School of Medicine at Mount Sinai, New York
Тражи се учесникФаза 1
Узраст од 18 до 74 · Оба пола · Ажурирано 2. 11. 2026. · NCT07085104A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
- Nkarta Investigational Site, New York
- Nkarta Investigational Site, Syracuse
Тражи се учесникФаза 1/2
Узраст од 18 до 75 · Оба пола · Ажурирано 30. 10. 2026. · NCT06733935RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
- Columbia University Irving Medical Center, New York
- University of Rochester, Rochester
Тражи се учесникФаза 2/3
Узраст од 18 до 75 · Оба пола · Ажурирано 16. 10. 2026. · NCT06328777A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
- Hospital for Special Surgery, New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Medical Center-New York Presbyterian Hospital, New York
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 14. 10. 2026. · NCT07497087A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, New York
- GSK Investigational Site, New York
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 8. 9. 2026. · NCT05878717Platform Clinical Study for Conquering Scleroderma
- Northwell Health, Great Neck
- Hospital for Special Surgery, New York
- Columbia University Medical Center, New York
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 18. 8. 2026. · NCT06195072A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Montefiore Medical Center, New York
Тражи се учесникФаза 1
Узраст од 12 до 70 · Оба пола · Ажурирано 22. 5. 2026. · NCT06308978Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
- aTyr Investigative Site, New York
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 7. 5. 2025. · NCT05892614Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.